Logo image of CBAT

CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

USA - NASDAQ:CBAT - US14986C1027 - Common Stock

0.8898 USD
-0.01 (-0.69%)
Last: 11/18/2025, 1:46:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CBAT. CBAT was compared to 91 industry peers in the Electrical Equipment industry. CBAT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CBAT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CBAT had negative earnings in the past year.
In the past year CBAT had a positive cash flow from operations.
In multiple years CBAT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CBAT reported negative operating cash flow in multiple years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

CBAT has a Return On Assets of -2.74%. This is in the better half of the industry: CBAT outperforms 61.54% of its industry peers.
The Return On Equity of CBAT (-7.73%) is better than 62.64% of its industry peers.
Industry RankSector Rank
ROA -2.74%
ROE -7.73%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

CBAT's Profit Margin has declined in the last couple of years.
The Gross Margin of CBAT (17.22%) is worse than 61.54% of its industry peers.
CBAT's Gross Margin has improved in the last couple of years.
CBAT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

3

2. Health

2.1 Basic Checks

CBAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
CBAT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CBAT has been increased compared to 5 years ago.
The debt/assets ratio for CBAT has been reduced compared to a year ago.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CBAT has an Altman-Z score of -0.15. This is a bad value and indicates that CBAT is not financially healthy and even has some risk of bankruptcy.
CBAT has a Altman-Z score (-0.15) which is comparable to the rest of the industry.
The Debt to FCF ratio of CBAT is 14.55, which is on the high side as it means it would take CBAT, 14.55 years of fcf income to pay off all of its debts.
CBAT has a better Debt to FCF ratio (14.55) than 65.93% of its industry peers.
CBAT has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.33, CBAT is in line with its industry, outperforming 51.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 14.56
Altman-Z -0.15
ROIC/WACCN/A
WACC5.77%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.72 indicates that CBAT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.72, CBAT is doing worse than 83.52% of the companies in the same industry.
A Quick Ratio of 0.53 indicates that CBAT may have some problems paying its short term obligations.
The Quick ratio of CBAT (0.53) is worse than 80.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.53
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The earnings per share for CBAT have decreased strongly by -141.18% in the last year.
Measured over the past years, CBAT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -42.83% on average per year.
Looking at the last year, CBAT shows a very negative growth in Revenue. The Revenue has decreased by -13.61% in the last year.
CBAT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.40% yearly.
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-13.61%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%

3.2 Future

Based on estimates for the next years, CBAT will show a very negative growth in Earnings Per Share. The EPS will decrease by -20.77% on average per year.
CBAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.65% yearly.
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-22.1%
Revenue Next 2Y11.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.1 -0.1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CBAT. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 10.90, which indicates a very decent valuation of CBAT.
94.51% of the companies in the same industry are more expensive than CBAT, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.62, CBAT is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 10.9
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CBAT is valued a bit cheaper than 78.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.37
EV/EBITDA -17.1
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A cheap valuation may be justified as CBAT's earnings are expected to decrease with -20.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CBAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (11/18/2025, 1:46:01 PM)

0.8898

-0.01 (-0.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-10 2025-11-10/bmo
Earnings (Next)03-16 2026-03-16/bmo
Inst Owners2.19%
Inst Owner Change25.15%
Ins Owners25.81%
Ins Owner Change0%
Market Cap78.88M
Revenue(TTM)176.61M
Net Income(TTM)-9.14M
Analysts0
Price Target1.53 (71.95%)
Short Float %0.25%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.97%
Min Revenue beat(2)-34.33%
Max Revenue beat(2)18.4%
Revenue beat(4)1
Avg Revenue beat(4)-22.71%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)18.4%
Revenue beat(8)2
Avg Revenue beat(8)-15.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)13.31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.9
P/S 0.54
P/FCF 29.37
P/OCF 2.33
P/B 0.67
P/tB 0.67
EV/EBITDA -17.1
EPS(TTM)-0.07
EYN/A
EPS(NY)0.08
Fwd EY9.17%
FCF(TTM)0.03
FCFY3.41%
OCF(TTM)0.38
OCFY42.92%
SpS1.64
BVpS1.33
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.74%
ROE -7.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.22%
FCFM 1.85%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 14.56
Debt/EBITDA 449.35
Cap/Depr 393.66%
Cap/Sales 21.43%
Interest Coverage N/A
Cash Conversion 38910.2%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.53
Altman-Z -0.15
F-Score2
WACC5.77%
ROIC/WACCN/A
Cap/Depr(3y)245.38%
Cap/Depr(5y)296.85%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.18%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.61%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%36.52%
Revenue Next Year-22.1%
Revenue Next 2Y11.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-127.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y121.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y148.91%
OCF growth 3YN/A
OCF growth 5YN/A

CBAK ENERGY TECHNOLOGY INC / CBAT FAQ

What is the fundamental rating for CBAT stock?

ChartMill assigns a fundamental rating of 3 / 10 to CBAT.


Can you provide the valuation status for CBAK ENERGY TECHNOLOGY INC?

ChartMill assigns a valuation rating of 4 / 10 to CBAK ENERGY TECHNOLOGY INC (CBAT). This can be considered as Fairly Valued.


How profitable is CBAK ENERGY TECHNOLOGY INC (CBAT) stock?

CBAK ENERGY TECHNOLOGY INC (CBAT) has a profitability rating of 2 / 10.